期刊文献+

唐氏综合征产前血清筛查的进展 被引量:20

Advance in prenatal screening for Down's syndrome with use of maternal serum markers.
在线阅读 下载PDF
导出
摘要 1886年英国LangDown首先对此病作了描述。此病因严重智力发育迟缓,肌张力低下,小头畸形,宽眼距等而引起临床上关注,称唐氏综合征(Downsyndome,Ds)。作为21三体染色体疾病,首先是法国儿科医生Lejeune于1959年证实的。Ds是... The aim of maternal serum screening (MSS) is to define patients at inscreased risk for Down's syndrome (Ds). During past ten years, the western researchers of prenatal diagnosis for Ds have done a lot of valuable work. In 1996 International Prenatal Screening Group's study gave conclusion: The performance of screening using maternal age and serum free bate hCG and PAPP A at ten weeks of pregnancies was better combination of MSS. It's early enough for the pregnancy woman given positive result to be performed further diagnosis by CVS or Ac. MSS is helpful to prenatal diagnosis for Ds has been demonstrated by many laboratories. Some researchers in asian countries or areas have made prospective studies on MSS for fetal Ds. Because most pregnanceny women don't understand the meaning of 'increased risk'. It's necessary to make it clear to them and offer genetics consultant in time.
作者 钟红菱
出处 《中国优生与遗传杂志》 1998年第4期1-4,共4页 Chinese Journal of Birth Health & Heredity
关键词 唐氏综合征 产前血清筛查 血清因子 母血 Prenatal screening, Down's syndrome, Maternal serum, Review.
  • 相关文献

同被引文献82

引证文献20

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部